Effective Date: October 1, 2018
Updated: December 10, 2019
Effective Date: October 1, 2018
Updated: December 10, 2019
Life360 Innovations Inc. (Life360 or the Company), a wholly owned subsidiary of Life360 Innovations Holdings Inc., was is a Canadian private corporation that imagines, manufactures and distributes medical devices and products. The Contino® medical devices for male stress urinary incontinence are our flagship products.
The story of the invention of Contino® can be found here.
The bios of key team members can be found here.
Yes, as part of the development of our products and submission to Health Canada, Life360 developed an ISO 13485:2016 quality management system. Our system is compliant with applicable Canada, EU and US standards.
The Contino® urethral insert is a self-administered licensed medical device that controls bladder leakage in men. Much more than just a device, Contino® is an integrated solution that includes personalised fitting and support from incontinence specialists, so men can get on with life.
To learn more about Contino®, visit mycontino.com.
Yes, Life360 received Health Canada Licenses to manufacture, distribute and sell Contino®.
The Contino® urethral insert is intended to reduce involuntary urine leakage by temporarily obstructing the urethra.
Contino® is indicated for males aged 18 years or older with urinary incontinence caused by bladder sphincteric incompetence.
To learn how Contino® works, click here.
Contino® is available through select physiotherapy and incontinence clinics, where an experienced incontinence specialist will conduct an independent assessment and provide personalised training.
Click here to find a Contino® Authorised Clinic near you.
You can also contact us for assistance.
The Contino® can be used daily, removing only to urinate.
The Contino® and Contino® Inserter are limited use reusable devices and will wear out over time and with use. The urethral insert is reusable for up to 30 daily uses, while the Inserter is reusable for up to 90 daily uses. One or more insertion in a single day is considered a daily use.
These devices are to be replaced the earlier of the recommended use (i.e. 30 or 90 daily uses) or noticeable wear including discolouring or stretching. Visually check the urethral insert and the Inserter prior to each use. If worn, they should be disposed and replaced with a new one. They should not be used beyond the recommended daily use.
The Contino® urethral insert and Contino® Inserter are for single patient use only.
Precautions, exclusions, and warnings are detailed in the Contino® Instructions for Use.
Contino® is not intended to be used with a full or near bladder, as it may release on its ownresulting in involuntary urine leakage. Contino® is not intended to be used during sexualintercourse.
Contino® is designed to withstand the forces applied to it during its intended use. Under normalconditions there is no reason to expect Contino® will break. The Contino® urethral insert willstretch over time and should be replaced the earlier of 30 daily uses or when it does not fitsnugly with the Contino® Inserter.
In the unlikely event that the urethral insert breaks and remains in your urethra – for whateverreason or circumstance – try to palpate the device out. If unsuccessful, please go to the nearestmedical clinic or Emergency Department to discuss your symptoms and obtain treatment. Besure to tell the attending doctor that you are using Contino® and bring a copy of the Contino®Instructions for Use.
Please report this situation to the your Contino® Authorised Clinic as soon as reasonablypossible.
You may experience some discomfort when you insert the Contino® the first few times. Yourbody may take a week or so to get used to the new device and procedures. However, youshould not feel significant discomfort and/or pain when you use a properly sized Contino® afteryour body has adapted to the device.
If you experience significant discomfort while using the Contino® during the trainingperiod, please consider using a smaller sized Contino®. If discomfort persists, contact thetraining center and/or Professional who will advise you on next steps.
These signs or symptoms may indicate you are experiencing bleeding, injury to the urethra, orsome form of an infection:
Please go to the nearest medical clinic or Emergency Department to discuss your symptomsand obtain treatment. Be sure to tell the attending physician that you are using the Contino®and bring a copy of these instructions for use. Please report this situation to the training centerand/or Professional as soon as reasonably possible.
The current version numbers of the Contino® Instructions for Use can be found here. If you are a Contino® client or Contino® Authorised Trainer and would like a copy of the latest instructions for use, please contact us.
Yes, all Contino® branded products come with a Limited Warranty. The limited warranty can be found here.
Maybe. Non-Contino® branded products may be covered by the product manufacturer. Review the product labeling for contact information.
Yes. Contino® clients who refer Contino® to men they know using their personal referral link will receive a Tim Hortons gift card of $5 per qualified lead, up to a total of $50 per year, and a $50 credit towards their next subscription payment per qualified referral, up to a total of $150 per year. Referred clients will receive $50 off their initial subscription payment. See the Referral Program Terms & Conditions for details.
Urinary Incontinence (UI) is defined as the involuntary leakage of urine. UI is a debilitating condition that impacts the physical and emotional wellbeing of sufferers.
The main types of UI are:
The Canadian Continence Foundation (CCF) estimates that 3.5 million Canadians experience UI. The Canadian Urinary Bladder Survey estimates that 16% of men and 33% of women over 40 have UI.
The size of the Canadian market is significant, with over 1.1 million male UI sufferers, of which approximately 270,000 have stress UI. CCF commissioned Incontinence: The Canadian Perspective and highlighted the following:
CCF estimates that the annual direct costs of UI are approximately $1,400 to $2,100 for a Canadian senior living at home (i.e. for incontinence supplies) and approximately $4,000 to $14,000 for a Canadian senior living in a long-term care facility (i.e. for supplies plus direct nursing care). After considering laundry, clothing and linen changes, as well as supply costs and non-nursing time, the total direct costs of UI in Canada exceed $1 billion per year.
The leading causes of UI in men include: